Biostatistics Department, 89bio, Inc., San Francisco, California, USA.
Department of Mathematics, Statistics, and Computer Science, University of Illinois at Chicago, Chicago, Illinois.
Stat Med. 2024 May 30;43(12):2472-2485. doi: 10.1002/sim.10082. Epub 2024 Apr 11.
The statistical methodology for model-based dose finding under model uncertainty has attracted increasing attention in recent years. While the underlying principles are simple and easy to understand, developing and implementing an efficient approach for binary responses can be a formidable task in practice. Motivated by the statistical challenges encountered in a phase II dose finding study, we explore several key design and analysis issues related to the hybrid testing-modeling approaches for binary responses. The issues include candidate model selection and specifications, optimal design and efficient sample size allocations, and, notably, the methods for dose-response testing and estimation. Specifically, we consider a class of generalized linear models suited for the candidate set and establish D-optimal designs for these models. Additionally, we propose using permutation-based tests for dose-response testing to avoid asymptotic normality assumptions typically required for contrast-based tests. We perform trial simulations to enhance our understanding of these issues.
近年来,基于模型不确定性的模型引导剂量探索的统计方法引起了越来越多的关注。虽然基本原理简单易懂,但在实践中开发和实施针对二分类响应的有效方法可能是一项艰巨的任务。受 II 期剂量探索研究中遇到的统计挑战的启发,我们探讨了与二分类响应的混合测试-建模方法相关的几个关键设计和分析问题。这些问题包括候选模型选择和规范、最优设计和有效样本量分配,以及特别重要的剂量-反应测试和估计方法。具体来说,我们考虑了一类适合候选集的广义线性模型,并为这些模型建立了 D 最优设计。此外,我们建议使用基于置换的检验来进行剂量-反应检验,以避免通常对比检验所需的渐近正态性假设。我们进行了试验模拟,以加深对这些问题的理解。